TipRanks
Advertisement
Advertisement
Cassava Sciences Securities Litigation Ruling: Court Denies Ugarte Dismissal Motions Without Prejudice While Awaiting Fifth Circuit Ruling 
PremiumClass ActionCassava Sciences Securities Litigation Ruling: Court Denies Ugarte Dismissal Motions Without Prejudice While Awaiting Fifth Circuit Ruling 
2M ago
FLNA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
FLNA Earnings this Week: How Will it Perform?
2M ago
Jason McCarthy Reiterates Buy on Filana, Maintains Unchanged $5 Price Target Amid Advancing Simufilam TSC Epilepsy Strategy
Premium
Ratings
Jason McCarthy Reiterates Buy on Filana, Maintains Unchanged $5 Price Target Amid Advancing Simufilam TSC Epilepsy Strategy
2M ago
Filana Therapeutics publishes simufilam preclinical data
PremiumThe FlyFilana Therapeutics publishes simufilam preclinical data
6M ago
Filana Therapeutics management to meet with Maxim
Premium
The Fly
Filana Therapeutics management to meet with Maxim
7M ago
Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year
Premium
The Fly
Filana Therapeutics reports Q4 EPS (26c) vs. (57c) last year
7M ago
Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M
PremiumThe FlyFilana Therapeutics sees 1H26 net cash use in operations $14M-$17M
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―